Pharmacogenomically actionable medications in a safety net health care system

OBJECTIVE: Prior to implementing a trial to evaluate the economic costs and clinical outcomes of pharmacogenetic testing in a large safety net health care system, we determined the number of patients taking targeted medications and their clinical care encounter sites. METHODS: Using 1-year electroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpenter, Janet S, Rosenman, Marc B, Knisely, Mitchell R, Decker, Brian S, Levy, Kenneth D, Flockhart, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724767/
https://www.ncbi.nlm.nih.gov/pubmed/26835014
http://dx.doi.org/10.1177/2050312115624333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724767/
https://www.ncbi.nlm.nih.gov/pubmed/26835014
http://dx.doi.org/10.1177/2050312115624333

Ejemplares similares